BR
Therapeutic Areas
AngioInsight Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AngioAI+™ Platform | Diagnosis and management of Coronary Artery Disease (CAD) and Coronary Microvascular Disease (CMD) | Investigational |
Leadership Team at AngioInsight
SB
Scott Burger
Chief Executive Officer
VP
Vas Paruchuri, PhD
Chief Technical Officer
TV
Todd Villines, MD
Chief Medical Officer
BN
Brahmajee Nallamothu, MD
Co-Founder, Medical Advisor
AF
Alberto Figueroa, PhD
Co-Founder, Chief Science Officer
GZ
Gabrielle Zaeska
SVP, Regulatory Affairs and Quality